Clinical Trial: A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232589) titled 'A Study of the Effect of Diltiazem on the Plasma Levels of Nemtabrutinib (MK-1026-022)' on Nov. 14.

Brief Summary: The goal of the study is to learn what happens to levels of nemtabrutinib (MK-1026) in a healthy person's body over time. Researchers will compare what happens to nemtabrutinib in the body when it is given with or without another medicine called diltiazem.

Study Start Date: Dec. 08

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: Nemtabrutinib

Oral administration

DRUG: Diltiazem

Oral administration

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Merck Sharp & Dohme LLC

Disclaimer: Curated by...